儿童癌症幸存者在肿瘤治疗期间及之后的骨密度:系统综述与Meta分析
该系统综述与Meta分析纳入49项研究(4547名参与者),评估儿童癌症患者治疗期间及幸存者治疗后的骨密度Z值变化。治疗期间各部位骨密度Z值较基线下降(平均差值-0.36,95%CI -0.62至-0.11;p=.01),儿童青少年幸存者腰椎(-0.85 SD)和髋部/股骨颈(-1.03 SD)及成人幸存者腰椎(-0.46 SD)和髋部/股骨颈(-0.36 SD)骨密度Z值均持续偏低。
要点
- 儿童癌症治疗期间骨密度Z值较基线下降(平均差值-0.36,95%CI -0.62至-0.11)。
- 儿童青少年幸存者腰椎和髋部/股骨颈骨密度Z值分别为-0.85 SD和-1.03 SD。
- 成人幸存者腰椎和髋部/股骨颈骨密度Z值分别为-0.46 SD和-0.36 SD。
核心结论
- 儿童癌症患者和幸存者骨密度降低。
- 未来研究应评估规律体力活动、针对性运动医学和营养治疗作为一线对策以减轻骨健康下降的影响。
研究设计与样本
- 系统综述与三级混合效应Meta分析,检索CINAHL、Embase、PubMed、SPORTDiscus和Web of Science数据库自建库至2023年11月。
- 纳入49项研究(4547名参与者),对象为18岁前诊断癌症、正在接受或已完成治疗的儿童和青少年,报告双能X线吸收法测定的腰椎、髋部/股骨颈或全身骨密度Z值。
主要发现
- 治疗期间各部位骨密度Z值较基线下降(平均差值-0.36,95%CI -0.62至-0.11;p=.01)。
- 儿童青少年幸存者腰椎骨密度Z值为-0.85 SD(95%CI -1.17至-0.54;p<.001),髋部/股骨颈为-1.03 SD(95%CI -1.38至-0.68;p<.001)。
- 成人幸存者腰椎骨密度Z值为-0.46 SD(95%CI -0.67至-0.26;p<.001),髋部/股骨颈为-0.36 SD(95%CI -0.57至-0.16;p<.001)。
- 髋部/股骨颈骨密度Z值受评估时年龄(p=.006)、诊断后时间(p=.004)、性别(p=.037)和身高(p=.026)调节。
- 腰椎骨密度Z值受评估时年龄(p=.018)和性别(p=.015)调节。
局限性
- 未来研究应评估规律体力活动、针对性运动医学和营养治疗作为一线对策以减轻骨健康下降的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoporosis poses a significant concern for childhood cancer survivors (CCS). While recommendations for surveillance and management of bone mineral density (BMD) exist, no systematic review and meta-analysis has been undertaken to quantify BMD Z-scores in childhood cancer patients undergoing cancer treatment and survivors who have completed treatments. Accordingly, we conducted a systematic review with a 3-level mixed-effects meta-analysis to examine the course of BMD Z-scores in childhood cancer patients and survivors and identified possible moderators using meta-regression models. A systematic search was conducted in CINAHL, Embase, PubMed, SPORTDiscus, and Web of Science databases from inception to November 2023. We included studies that involved children and adolescents diagnosed with cancer before the age of 18 who were undergoing cancer treatment or had completed treatments and reported lumbar spine, hip/femoral neck, or total body BMD Z-scores derived from dual-energy x-ray absorptiometry. Forty-nine studies (4547 participants) were included in the meta-analysis. BMD Z-scores across different sites decreased with respect to baseline in children undergoing cancer treatment (mean difference: - 0.36, 95% CI - 0.62 to - 0.11; p = .01) and remained low following treatment in child and adolescent CCS (lumbar spine: - 0.85 SD, 95% CI - 1.17 to - 0.54; p < .001; hip/femoral neck: - 1.03 SD, 95% CI - 1.38 to - 0.68; p < .001), and adult CCS (lumbar spine: - 0.46 SD, 95% CI - 0.67 to - 0.26; p < .001; hip/femoral neck: - 0.36 SD, 95% CI - 0.57 to - 0.16; p < .001). Hip/femoral neck BMD Z-scores were moderated by age at assessment (p = .006), time from diagnosis (p = .004), sex (p = .037), and height (p = .026). Lumbar spine BMD Z-scores were moderated by age at assessment (p = .018), and sex (p = .015). In conclusion, childhood cancer patients and survivors experience reductions in BMD. Future research should evaluate the implications of regular physical activity, targeted exercise medicine, and nutrition therapy as first-line countermeasures to mitigate the declines in bone health.
引用
- Markarian AM, Taaffe DR, Bettariga F, et al. Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis. Osteoporos Int. 2025. PMID: 40146277. doi:10.1007/s00198-025-07458-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。